Generic Medrol (Methylprednisolone)
Inflammation, immunosuppression
ApprovedActive (Launched)
Key Facts
Indication
Inflammation, immunosuppression
Phase
Approved
Status
Active (Launched)
Company
About Praxgen Pharmaceuticals
Praxgen Pharmaceuticals, founded in 2016 and headquartered in San Diego with key operations in New Jersey, is a private, commercial-stage generic drug developer. The company has a strategic focus on complex generics, with over 40 products in development and a track record of ANDA approvals and product launches, such as generic Medrol and Fosaprepitant. Leveraging a hybrid model of in-house R&D and external manufacturing partnerships, Praxgen aims to capture value in high-barrier, high-market-size generic drug segments while navigating the competitive and regulatory pressures inherent to the industry.
View full company profile